Prevention of Neural Tube Defects in Europe: A Public Health Failure

Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first t...

Full description

Bibliographic Details
Main Authors: Joan K. Morris, Marie-Claude Addor, Elisa Ballardini, Ingeborg Barisic, Laia Barrachina-Bonet, Paula Braz, Clara Cavero-Carbonell, Elly Den Hond, Ester Garne, Miriam Gatt, Martin Haeusler, Babak Khoshnood, Nathalie Lelong, Agnieszka Kinsner-Ovaskainen, Sonja Kiuru-Kuhlefelt, Kari Klungsoyr, Anna Latos-Bielenska, Elizabeth Limb, Mary T O'Mahony, Isabelle Perthus, Anna Pierini, Judith Rankin, Anke Rissmann, Florence Rouget, Gerardine Sayers, Antonin Sipek, Sarah Stevens, David Tucker, Christine Verellen-Dumoulin, Hermien E. K. de Walle, Diana Wellesley, Wladimir Wertelecki, Eva Bermejo-Sanchez
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.647038/full
id doaj-57a0c1d9d13544888581528d0d4764a7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Joan K. Morris
Marie-Claude Addor
Elisa Ballardini
Ingeborg Barisic
Laia Barrachina-Bonet
Paula Braz
Clara Cavero-Carbonell
Elly Den Hond
Ester Garne
Miriam Gatt
Martin Haeusler
Babak Khoshnood
Nathalie Lelong
Agnieszka Kinsner-Ovaskainen
Sonja Kiuru-Kuhlefelt
Kari Klungsoyr
Kari Klungsoyr
Anna Latos-Bielenska
Elizabeth Limb
Mary T O'Mahony
Isabelle Perthus
Anna Pierini
Judith Rankin
Anke Rissmann
Florence Rouget
Gerardine Sayers
Antonin Sipek
Sarah Stevens
David Tucker
Christine Verellen-Dumoulin
Hermien E. K. de Walle
Diana Wellesley
Wladimir Wertelecki
Eva Bermejo-Sanchez
spellingShingle Joan K. Morris
Marie-Claude Addor
Elisa Ballardini
Ingeborg Barisic
Laia Barrachina-Bonet
Paula Braz
Clara Cavero-Carbonell
Elly Den Hond
Ester Garne
Miriam Gatt
Martin Haeusler
Babak Khoshnood
Nathalie Lelong
Agnieszka Kinsner-Ovaskainen
Sonja Kiuru-Kuhlefelt
Kari Klungsoyr
Kari Klungsoyr
Anna Latos-Bielenska
Elizabeth Limb
Mary T O'Mahony
Isabelle Perthus
Anna Pierini
Judith Rankin
Anke Rissmann
Florence Rouget
Gerardine Sayers
Antonin Sipek
Sarah Stevens
David Tucker
Christine Verellen-Dumoulin
Hermien E. K. de Walle
Diana Wellesley
Wladimir Wertelecki
Eva Bermejo-Sanchez
Prevention of Neural Tube Defects in Europe: A Public Health Failure
Frontiers in Pediatrics
neural tube defects
prevention
folic acid
fortification
Europe
author_facet Joan K. Morris
Marie-Claude Addor
Elisa Ballardini
Ingeborg Barisic
Laia Barrachina-Bonet
Paula Braz
Clara Cavero-Carbonell
Elly Den Hond
Ester Garne
Miriam Gatt
Martin Haeusler
Babak Khoshnood
Nathalie Lelong
Agnieszka Kinsner-Ovaskainen
Sonja Kiuru-Kuhlefelt
Kari Klungsoyr
Kari Klungsoyr
Anna Latos-Bielenska
Elizabeth Limb
Mary T O'Mahony
Isabelle Perthus
Anna Pierini
Judith Rankin
Anke Rissmann
Florence Rouget
Gerardine Sayers
Antonin Sipek
Sarah Stevens
David Tucker
Christine Verellen-Dumoulin
Hermien E. K. de Walle
Diana Wellesley
Wladimir Wertelecki
Eva Bermejo-Sanchez
author_sort Joan K. Morris
title Prevention of Neural Tube Defects in Europe: A Public Health Failure
title_short Prevention of Neural Tube Defects in Europe: A Public Health Failure
title_full Prevention of Neural Tube Defects in Europe: A Public Health Failure
title_fullStr Prevention of Neural Tube Defects in Europe: A Public Health Failure
title_full_unstemmed Prevention of Neural Tube Defects in Europe: A Public Health Failure
title_sort prevention of neural tube defects in europe: a public health failure
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2021-06-01
description Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA.Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation.Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements.Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.
topic neural tube defects
prevention
folic acid
fortification
Europe
url https://www.frontiersin.org/articles/10.3389/fped.2021.647038/full
work_keys_str_mv AT joankmorris preventionofneuraltubedefectsineuropeapublichealthfailure
AT marieclaudeaddor preventionofneuraltubedefectsineuropeapublichealthfailure
AT elisaballardini preventionofneuraltubedefectsineuropeapublichealthfailure
AT ingeborgbarisic preventionofneuraltubedefectsineuropeapublichealthfailure
AT laiabarrachinabonet preventionofneuraltubedefectsineuropeapublichealthfailure
AT paulabraz preventionofneuraltubedefectsineuropeapublichealthfailure
AT claracaverocarbonell preventionofneuraltubedefectsineuropeapublichealthfailure
AT ellydenhond preventionofneuraltubedefectsineuropeapublichealthfailure
AT estergarne preventionofneuraltubedefectsineuropeapublichealthfailure
AT miriamgatt preventionofneuraltubedefectsineuropeapublichealthfailure
AT martinhaeusler preventionofneuraltubedefectsineuropeapublichealthfailure
AT babakkhoshnood preventionofneuraltubedefectsineuropeapublichealthfailure
AT nathalielelong preventionofneuraltubedefectsineuropeapublichealthfailure
AT agnieszkakinsnerovaskainen preventionofneuraltubedefectsineuropeapublichealthfailure
AT sonjakiurukuhlefelt preventionofneuraltubedefectsineuropeapublichealthfailure
AT kariklungsoyr preventionofneuraltubedefectsineuropeapublichealthfailure
AT kariklungsoyr preventionofneuraltubedefectsineuropeapublichealthfailure
AT annalatosbielenska preventionofneuraltubedefectsineuropeapublichealthfailure
AT elizabethlimb preventionofneuraltubedefectsineuropeapublichealthfailure
AT marytomahony preventionofneuraltubedefectsineuropeapublichealthfailure
AT isabelleperthus preventionofneuraltubedefectsineuropeapublichealthfailure
AT annapierini preventionofneuraltubedefectsineuropeapublichealthfailure
AT judithrankin preventionofneuraltubedefectsineuropeapublichealthfailure
AT ankerissmann preventionofneuraltubedefectsineuropeapublichealthfailure
AT florencerouget preventionofneuraltubedefectsineuropeapublichealthfailure
AT gerardinesayers preventionofneuraltubedefectsineuropeapublichealthfailure
AT antoninsipek preventionofneuraltubedefectsineuropeapublichealthfailure
AT sarahstevens preventionofneuraltubedefectsineuropeapublichealthfailure
AT davidtucker preventionofneuraltubedefectsineuropeapublichealthfailure
AT christineverellendumoulin preventionofneuraltubedefectsineuropeapublichealthfailure
AT hermienekdewalle preventionofneuraltubedefectsineuropeapublichealthfailure
AT dianawellesley preventionofneuraltubedefectsineuropeapublichealthfailure
AT wladimirwertelecki preventionofneuraltubedefectsineuropeapublichealthfailure
AT evabermejosanchez preventionofneuraltubedefectsineuropeapublichealthfailure
_version_ 1721361546857152512
spelling doaj-57a0c1d9d13544888581528d0d4764a72021-06-24T05:53:23ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-06-01910.3389/fped.2021.647038647038Prevention of Neural Tube Defects in Europe: A Public Health FailureJoan K. Morris0Marie-Claude Addor1Elisa Ballardini2Ingeborg Barisic3Laia Barrachina-Bonet4Paula Braz5Clara Cavero-Carbonell6Elly Den Hond7Ester Garne8Miriam Gatt9Martin Haeusler10Babak Khoshnood11Nathalie Lelong12Agnieszka Kinsner-Ovaskainen13Sonja Kiuru-Kuhlefelt14Kari Klungsoyr15Kari Klungsoyr16Anna Latos-Bielenska17Elizabeth Limb18Mary T O'Mahony19Isabelle Perthus20Anna Pierini21Judith Rankin22Anke Rissmann23Florence Rouget24Gerardine Sayers25Antonin Sipek26Sarah Stevens27David Tucker28Christine Verellen-Dumoulin29Hermien E. K. de Walle30Diana Wellesley31Wladimir Wertelecki32Eva Bermejo-Sanchez33Population Health Research Institute, St. George's, University of London, London, United KingdomDepartment of Woman-Mother-Child, University Hospital Center, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandIndagine Sulle Malformazioni Congenite in Emilia-Romagna (IMER) Registry (Emilia Romagna Registry of Birth Defects) Neonatal Intensive Care Unit, Pediatric Section Department of Medical Sciences, University of Ferrara, Ferrara, ItalyCentre of Excellence for Reproductive and Regenerative Medicine, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, CroatiaRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, SpainEpidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisboa, PortugalRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, SpainHealth Department, Provincial Institute of Hygiene, Antwerp, BelgiumPaediatric Department, Hospital Lillebaelt Kolding, Kolding, DenmarkDirectorate for Health Information and Research, Pietà, Malta0Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria1Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France1Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France2European Commission, Joint Research Centre, Ispra, Italy3Finnish Institute for Health and Welfare Terveyden Ja Hyvinvoinnin Laitos (THL), Register of Congenital Malformations, Helsinki, Finland4Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway5Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway6Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, PolandPopulation Health Research Institute, St. George's, University of London, London, United Kingdom7Health Service Executive-South, Department of Public Health, St. Finbarr's Hospital, Cork, Ireland8Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, CHU Estaing, Clermont-Ferrand, France9Institute of Clinical Physiology, National Research Council, Pisa, Italy0Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom1Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University, Magdeburg, Germany2Brittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, INSERM, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France3Health Intelligence R&D Health Service Executive, Dublin, Ireland4Department of Medical Biology and Genetics, 1st Faculty of Medicine, General University Hospital, Charles University, Prague, Czechia5Public Health England, London, United Kingdom6Congenital Anomaly Register and Information Service for Wales, Public Health Wales Knowledge Directorate, Singleton Hospital, Swansea, United Kingdom7Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi, Belgium8Department of Genetics, Eurocat Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, Netherlands9Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom0OMNI-Net Ukraine Programs, Rivne, Ukraine1Spanish Collaborative Study of Congenital Malformations (ECEMC), Unidad de Investigación sobre Anomalías Congénitas, Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, SpainObjective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA.Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation.Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements.Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.https://www.frontiersin.org/articles/10.3389/fped.2021.647038/fullneural tube defectspreventionfolic acidfortificationEurope